EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Statement Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ Hitachi Chemical +
@ Kuraray +
@ The Nippon Synthetic Chemical Industry +
@ 持田製薬 +
@ Aica Kogyo +
@ Sekisui Chemical +
@ ROHTO PHARMACEUTICAL +
@ キッセイ薬品工業 +
@ 長谷川香料 +
@ NIPPON KAYAKU +
@ Otsuka Holdings +
@ Takeda Pharmaceutical +
@ ADEKA +
@ Mitsubishi Tanabe Pharma +
@ Nichi-Iko Pharmaceutical +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
SANKEI CHEMICAL
graph
ROHM
graph
NIPPON COKE & ENGINEERING
graph
クラリオン
graph
クラリオン
graph

Financial Statement Details: Fuso Pharmaceutical Industries (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Statement data

U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 63 B
 *  Net: ¥ 25 B
 (Ratio: 40.34%)
[BS] 2010-03-31
 *  Total: ¥ 63 B
 *  Net: ¥ 25 B
 (Ratio: 40.69%)
[BS] 2011-03-31
 *  Total: ¥ 59 B
 *  Net: ¥ 26 B
 (Ratio: 44.17%)
[BS] 2012-03-31
 *  Total: ¥ 61 B
 *  Net: ¥ 26 B
 (Ratio: 43.23%)
[BS] 2013-03-31
 *  Total: ¥ 71 B
 *  Net: ¥ 33 B
 (Ratio: 46.06%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 3 B ¥ 3 B ¥ 3 B ¥ 4 B ¥ 9 B
Other Current Assets ¥ 28 B ¥ 29 B ¥ 26 B ¥ 27 B ¥ 31 B
Tangible Assets ¥ 26 B ¥ 25 B ¥ 24 B ¥ 23 B ¥ 22 B
Intangible Assets ¥ 248 M ¥ 200 M ¥ 201 M ¥ 166 M ¥ 376 M
Investment etc. ¥ 5 B ¥ 5 B ¥ 5 B ¥ 5 B ¥ 8 B
Total Assets ¥ 63 B ¥ 63 B ¥ 59 B ¥ 61 B ¥ 71 B
Current Liabilities ¥ 27 B ¥ 27 B ¥ 23 B ¥ 24 B ¥ 27 B
Fixed Liabilities ¥ 10 B ¥ 10 B ¥ 9 B ¥ 10 B ¥ 11 B
Capital stock ¥ 10 B ¥ 10 B ¥ 10 B ¥ 10 B ¥ 10 B
Capital surplus etc. ¥ 15 B ¥ 15 B ¥ 15 B ¥ 15 B ¥ 22 B
Liabilities and net assets ¥ 63 B ¥ 63 B ¥ 59 B ¥ 61 B ¥ 71 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 45 B
 *  Income: ¥ -931 M
 (Ratio: -2.03%)
[PL] 2010-03-31
 *  Sales: ¥ 46 B
 *  Income: ¥ 518 M
 (Ratio: 1.11%)
[PL] 2011-03-31
 *  Sales: ¥ 47 B
 *  Income: ¥ 1 B
 (Ratio: 2.41%)
[PL] 2012-03-31
 *  Sales: ¥ 44 B
 *  Income: ¥ 372 M
 (Ratio: 0.84%)
[PL] 2013-03-31
 *  Sales: ¥ 48 B
 *  Income: ¥ 4 B
 (Ratio: 10.02%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 45 B ¥ 46 B ¥ 47 B ¥ 44 B ¥ 48 B
Cost of Sales ¥ 32 B ¥ 32 B ¥ 33 B ¥ 32 B ¥ 33 B
Gross profit ¥ 13 B ¥ 13 B ¥ 13 B ¥ 12 B ¥ 15 B
Other income ¥ 393 M ¥ 1 B ¥ 435 M ¥ 594 M ¥ 3 B
SG&A ¥ 13 B ¥ 13 B ¥ 11 B ¥ 11 B ¥ 11 B
Other expenses ¥ 1 B ¥ 1 B ¥ 1 B ¥ 703 M ¥ 2 B
Net income ¥ -931 M ¥ 518 M ¥ 1 B ¥ 372 M ¥ 4 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Operating CF
  • Investment CF
  • Financial CF
  • Foreign Exchange Effects
  • Net Change in Cash
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
[CF] 2009-03-31
 *  OCF: ¥ 1 B
 *  Cash: ¥ -1 B
[CF] 2010-03-31
 *  OCF: ¥ 2 B
 *  Cash: ¥ -125 M
[CF] 2011-03-31
 *  OCF: ¥ 6 B
 *  Cash: ¥ +795 M
[CF] 2012-03-31
 *  OCF: ¥ 884 M
 *  Cash: ¥ +445 M
[CF] 2013-03-31
 *  OCF: ¥ 3 B
 *  Cash: ¥ +4 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Operating CF ¥ 1 B ¥ 2 B ¥ 6 B ¥ 884 M ¥ 3 B
Investment CF ¥ -2 B ¥ -1 B ¥ -1 B ¥ -1 B ¥ 2 B
Financial CF ¥ 55 M ¥ -878 M ¥ -4 B ¥ 943 M ¥ -832 M
Foreign Exchange Effects ¥ -6 M ¥ -6 M ¥ -13 M ¥ -1 M -
Net Change in Cash ¥ -1 B ¥ -125 M ¥ 795 M ¥ 445 M ¥ 4 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ -931 M
 *  Net: ¥ -2 B
[SS] 2010-03-31
 *  Income: ¥ 518 M
 *  Net: ¥ +117 M
[SS] 2011-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +373 M
[SS] 2012-03-31
 *  Income: ¥ 372 M
 *  Net: ¥ +335 M
[SS] 2013-03-31
 *  Income: ¥ 4 B
 *  Net: ¥ +6 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Issuance of new shares - - - - -
Dividends from surplus ¥ -543 M ¥ -543 M ¥ -543 M ¥ -543 M ¥ -543 M
Net income ¥ -931 M ¥ 518 M ¥ 1 B ¥ 372 M ¥ 4 B
Purchase of treasury stock ¥ -20 M ¥ -7 M ¥ -8 M ¥ -3 M ¥ -5 M
Other Change in Stockholders Equity ¥ -1 M ¥ 74 M ¥ 1 M - ¥ 312 M
Other Change in Net Assets ¥ -735 M ¥ 75 M ¥ -221 M ¥ 509 M ¥ 1 B
Net Change in Net Assets ¥ -2 B ¥ 117 M ¥ 373 M ¥ 335 M ¥ 6 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 64 B
 *  Net: ¥ 26 B
 (Ratio: 41.50%)
[BS] 2010-03-31
 *  Total: ¥ 63 B
 *  Net: ¥ 26 B
 (Ratio: 41.84%)
[BS] 2011-03-31
 *  Total: ¥ 59 B
 *  Net: ¥ 27 B
 (Ratio: 45.15%)
[BS] 2012-03-31
 *  Total: ¥ 61 B
 *  Net: ¥ 27 B
 (Ratio: 44.03%)
[BS] 2013-03-31
 *  Total: ¥ 71 B
 *  Net: ¥ 33 B
 (Ratio: 47.03%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 3 B ¥ 3 B ¥ 3 B ¥ 4 B -
Other Current Assets ¥ 28 B ¥ 29 B ¥ 26 B ¥ 27 B -
Tangible Assets ¥ 26 B ¥ 24 B ¥ 23 B ¥ 23 B -
Intangible Assets ¥ 248 M ¥ 200 M ¥ 201 M ¥ 166 M -
Investment etc. ¥ 5 B ¥ 6 B ¥ 6 B ¥ 6 B ¥ 71 B
Total Assets ¥ 64 B ¥ 63 B ¥ 59 B ¥ 61 B ¥ 71 B
Current Liabilities ¥ 27 B ¥ 27 B ¥ 23 B ¥ 24 B ¥ 38 B
Fixed Liabilities ¥ 9 B ¥ 9 B ¥ 9 B ¥ 10 B -
Capital stock ¥ 10 B ¥ 10 B ¥ 10 B ¥ 10 B -
Capital surplus etc. ¥ 15 B ¥ 15 B ¥ 16 B ¥ 16 B ¥ 33 B
Liabilities and net assets ¥ 64 B ¥ 63 B ¥ 59 B ¥ 61 B ¥ 71 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 45 B
 *  Income: ¥ -939 M
 (Ratio: -2.05%)
[PL] 2010-03-31
 *  Sales: ¥ 46 B
 *  Income: ¥ 511 M
 (Ratio: 1.10%)
[PL] 2011-03-31
 *  Sales: ¥ 47 B
 *  Income: ¥ 1 B
 (Ratio: 2.35%)
[PL] 2012-03-31
 *  Sales: ¥ 44 B
 *  Income: ¥ 266 M
 (Ratio: 0.60%)
[PL] 2013-03-31
 *  Sales: ¥ 48 B
 *  Income: ¥ 4 B
 (Ratio: 10.03%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 45 B ¥ 46 B ¥ 47 B ¥ 44 B ¥ 48 B
Cost of Sales ¥ 32 B ¥ 32 B ¥ 33 B ¥ 32 B ¥ 43 B
Gross profit ¥ 13 B ¥ 13 B ¥ 13 B ¥ 12 B ¥ 4 B
Other income ¥ 413 M ¥ 1 B ¥ 426 M ¥ 509 M -
SG&A ¥ 13 B ¥ 13 B ¥ 11 B ¥ 11 B -
Other expenses ¥ 1 B ¥ 1 B ¥ 1 B ¥ 703 M -
Net income ¥ -939 M ¥ 511 M ¥ 1 B ¥ 266 M ¥ 4 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ -939 M
 *  Net: ¥ -2 B
[SS] 2010-03-31
 *  Income: ¥ 511 M
 *  Net: ¥ +109 M
[SS] 2011-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +343 M
[SS] 2012-03-31
 *  Income: ¥ 266 M
 *  Net: ¥ +229 M
Financial Statement Details2009-03-312010-03-312011-03-312012-03-31
Issuance of new shares - - - -
Dividends from surplus ¥ -543 M ¥ -543 M ¥ -543 M ¥ -543 M
Net income ¥ -939 M ¥ 511 M ¥ 1 B ¥ 266 M
Purchase of treasury stock ¥ -20 M ¥ -7 M ¥ -8 M ¥ -3 M
Other Change in Stockholders Equity ¥ -2 M ¥ 73 M ¥ 1 M -
Other Change in Net Assets ¥ -735 M ¥ 75 M ¥ -221 M ¥ 509 M
Net Change in Net Assets ¥ -2 B ¥ 109 M ¥ 343 M ¥ 229 M

Consolidated :Balance sheet (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
  Net assets¥ 28 B¥ 25 B¥ 25 B¥ 26 B¥ 26 B¥ 33 B
   Cash and deposits¥ 4 B¥ 3 B¥ 3 B¥ 3 B¥ 4 B¥ 9 B
   Notes and accounts receivable-trade¥ 20 B¥ 21 B¥ 21 B¥ 19 B¥ 19 B¥ 22 B
    Merchandise and finished goods¥ 5 B¥ 6 B¥ 5 B¥ 6 B¥ 6 B
     Raw materials and supplies¥ 739 M¥ 950 M¥ 1 B¥ 1 B¥ 1 B
     Work in process¥ 176 M¥ 101 M¥ 82 M¥ 89 M¥ 122 M
   Deferred tax assets¥ 1 B¥ 635 M¥ 473 M¥ 570 M¥ 750 M¥ 747 M
    Allowance for doubtful accounts-¥ -2 M¥ -2 M¥ -2 M¥ -2 M¥ -2 M
   Other¥ 799 M¥ 637 M¥ 992 M¥ 193 M¥ 297 M¥ 164 M
   Current assets¥ 32 B¥ 31 B¥ 33 B¥ 30 B¥ 32 B¥ 40 B
    Buildings and structures¥ 30 B¥ 30 B¥ 28 B¥ 28 B¥ 29 B¥ 28 B
     Accumulated depreciation¥ -20 B¥ -20 B¥ -19 B¥ -20 B¥ -20 B¥ -20 B
     Buildings and structures, net¥ 10 B¥ 9 B¥ 9 B¥ 8 B¥ 8 B¥ 7 B
    Machinery, equipment and vehicles¥ 22 B¥ 23 B¥ 24 B¥ 24 B¥ 24 B¥ 24 B
     Accumulated depreciation¥ -19 B¥ -20 B¥ -20 B¥ -20 B¥ -21 B¥ -21 B
     Machinery, equipment and vehicles, net¥ 3 B¥ 3 B¥ 3 B¥ 3 B¥ 2 B¥ 2 B
    Land¥ 11 B¥ 11 B¥ 11 B¥ 11 B¥ 11 B¥ 9 B
    Lease assets¥ 7 M¥ 7 M¥ 7 M¥ 7 M¥ 13 M
     Accumulated depreciation-¥ -1 M¥ -3 M¥ -4 M¥ -6 M
     Lease assets, net¥ 6 M¥ 5 M¥ 3 M¥ 2 M¥ 6 M
    Construction in progress¥ 1 B¥ 1 B¥ 79 M¥ 124 M¥ 520 M¥ 1 B
     Other¥ 3 B¥ 4 B¥ 4 B¥ 4 B¥ 4 B¥ 4 B
      Accumulated depreciation¥ -3 B¥ -3 B¥ -3 B¥ -3 B¥ -3 B¥ -3 B
      Other, net¥ 615 M¥ 582 M¥ 598 M¥ 504 M¥ 453 M¥ 574 M
    Property, plant and equipment¥ 26 B¥ 26 B¥ 25 B¥ 24 B¥ 23 B¥ 22 B
    Intangible assets¥ 283 M¥ 248 M¥ 200 M¥ 201 M¥ 166 M¥ 376 M
     Investment securities¥ 3 B¥ 2 B¥ 2 B¥ 2 B¥ 2 B¥ 5 B
     Long-term loans receivable¥ 74 M¥ 62 M¥ 59 M¥ 48 M¥ 30 M¥ 20 M
     Other¥ 2 B¥ 2 B¥ 2 B¥ 2 B¥ 3 B¥ 2 B
      Allowance for doubtful accounts¥ -81 M-----
    Investments and other assets¥ 5 B¥ 5 B¥ 5 B¥ 5 B¥ 5 B¥ 8 B
   Noncurrent assets¥ 32 B¥ 32 B¥ 30 B¥ 29 B¥ 29 B¥ 30 B
  Assets¥ 65 B¥ 63 B¥ 63 B¥ 59 B¥ 61 B¥ 71 B
   Notes and accounts payable-trade¥ 10 B¥ 11 B¥ 11 B¥ 11 B¥ 11 B¥ 12 B
   Lease obligations¥ 1 M¥ 1 M¥ 1 M¥ 1 M¥ 2 M
    Provision for bonuses¥ 663 M¥ 749 M¥ 663 M¥ 805 M¥ 808 M¥ 946 M
    Provision for directors' bonuses¥ 1 M¥ 2 M¥ 20 M¥ 1 M¥ 50 M
    Provision for sales rebates¥ 291 M¥ 288 M¥ 287 M¥ 276 M¥ 278 M
    Provision for sales returns¥ 9 M¥ 20 M¥ 21 M¥ 9 M¥ 7 M¥ 7 M
    Accounts payable-other¥ 925 M¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Income taxes payable¥ 78 M¥ 46 M¥ 84 M¥ 62 M¥ 48 M¥ 2 B
    Deposits received¥ 3 B¥ 2 B¥ 2 B¥ 2 B¥ 2 B¥ 2 B
    Short-term loans payable¥ 8 B¥ 9 B¥ 9 B¥ 6 B¥ 6 B¥ 6 B
    Current portion of bonds¥ 750 M¥ 100 M¥ 100 M¥ 100 M¥ 100 M¥ 100 M
   Other¥ 1 B¥ 752 M¥ 834 M¥ 970 M¥ 1 B¥ 1 B
   Current liabilities¥ 26 B¥ 27 B¥ 27 B¥ 23 B¥ 24 B¥ 27 B
    Bonds payable¥ 650 M¥ 550 M¥ 450 M¥ 350 M¥ 250 M¥ 150 M
    Long-term loans payable¥ 6 B¥ 5 B¥ 5 B¥ 5 B¥ 6 B¥ 6 B
    Provision for retirement benefits¥ 408 M¥ 568 M¥ 843 M¥ 1 B¥ 1 B¥ 1 B
    Provision for directors' retirement benefits¥ 237 M¥ 235 M¥ 230 M¥ 243 M¥ 243 M¥ 257 M
   Lease obligations¥ 5 M¥ 3 M¥ 2 M-¥ 4 M
   Asset retirement obligations¥ 161 M¥ 164 M¥ 102 M
    Deferred tax liabilities¥ 1 B¥ 590 M¥ 589 M¥ 339 M¥ 220 M¥ 934 M
    Deferred tax liabilities for land revaluation¥ 2 B¥ 2 B¥ 2 B¥ 2 B¥ 1 B¥ 1 B
    Other¥ 141 M¥ 138 M¥ 135 M¥ 130 M¥ 114 M¥ 590 M
   Noncurrent liabilities¥ 11 B¥ 10 B¥ 10 B¥ 9 B¥ 10 B¥ 11 B
  Liabilities¥ 37 B¥ 38 B¥ 37 B¥ 33 B¥ 34 B¥ 38 B
   Capital stock¥ 10 B¥ 10 B¥ 10 B¥ 10 B¥ 10 B¥ 10 B
    Capital surplus¥ 15 B¥ 15 B¥ 15 B¥ 15 B¥ 15 B¥ 15 B
    Retained earnings¥ 7 B¥ 5 B¥ 5 B¥ 6 B¥ 6 B¥ 10 B
   Treasury stock¥ -1 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B
   Shareholders' equity¥ 31 B¥ 30 B¥ 30 B¥ 30 B¥ 30 B¥ 35 B
   Valuation difference on available-for-sale securities¥ 801 M¥ 60 M¥ 205 M¥ -2 M¥ 194 M¥ 2 B
   Deferred gains or losses on hedges¥ -51 M¥ -46 M¥ -43 M¥ -54 M¥ -21 M-
   Revaluation reserve for land¥ -4 B¥ -4 B¥ -4 B¥ -4 B¥ -4 B¥ -4 B
   Valuation and translation adjustments¥ -3 B¥ -4 B¥ -4 B¥ -4 B¥ -3 B¥ -2 B
 Liabilities and net assets¥ 65 B¥ 63 B¥ 63 B¥ 59 B¥ 61 B¥ 71 B
   Inventories¥ 5 B
Consolidated :Income statement (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
   Net sales¥ 43 B¥ 45 B¥ 46 B¥ 47 B¥ 44 B¥ 48 B
 Operating income¥ -439 M¥ 296 M¥ 463 M¥ 2 B¥ 480 M¥ 3 B
 Ordinary income¥ -670 M¥ 86 M¥ 51 M¥ 1 B¥ 74 M¥ 3 B
 Net income¥ 107 M¥ -931 M¥ 518 M¥ 1 B¥ 372 M¥ 4 B
 Comprehensive income¥ 924 M¥ 881 M¥ 7 B
   Cost of sales¥ 31 B¥ 32 B¥ 32 B¥ 33 B¥ 32 B¥ 33 B
    Selling, general and administrative expenses¥ 13 B¥ 13 B¥ 13 B¥ 11 B¥ 11 B¥ 11 B
 Gross profit¥ 12 B¥ 13 B¥ 13 B¥ 13 B¥ 12 B¥ 15 B
  Gross profit-net¥ 12 B¥ 13 B¥ 13 B¥ 13 B¥ 12 B¥ 15 B
   Reversal of provision for sales returns¥ 4 M¥ 12 M¥ 2 M-
  Interest income¥ 22 M¥ 24 M¥ 24 M¥ 10 M¥ 6 M¥ 5 M
  Dividends income¥ 53 M¥ 50 M¥ 34 M¥ 46 M¥ 50 M¥ 45 M
  Gain on investments in partnership-¥ 217 M
  Other¥ 44 M¥ 96 M¥ 96 M¥ 115 M
  Non-operating income¥ 311 M¥ 294 M¥ 259 M¥ 229 M¥ 229 M¥ 462 M
  Interest expenses¥ 295 M¥ 297 M¥ 314 M¥ 306 M¥ 262 M¥ 263 M
  Loss on investments in partnership¥ 138 M¥ 59 M¥ 108 M¥ 37 M
  Other¥ 144 M¥ 138 M¥ 113 M¥ 83 M
  Non-operating expenses¥ 542 M¥ 504 M¥ 671 M¥ 756 M¥ 636 M¥ 514 M
  Gain on sales of noncurrent assets¥ 568 M¥ 202 M¥ 3 M-¥ 2 B
  Extraordinary income¥ 850 M¥ 99 M¥ 1 B¥ 46 M-¥ 2 B
  Impairment loss-¥ 319 M
  Loss on retirement of noncurrent assets¥ 84 M¥ 45 M¥ 128 M¥ 100 M¥ 67 M¥ 50 M
  Extraordinary loss¥ 133 M¥ 337 M¥ 680 M¥ 704 M¥ 67 M¥ 369 M
 Income before income taxes¥ 46 M¥ -151 M¥ 573 M¥ 984 M¥ 6 M¥ 6 B
 Income taxes¥ -60 M¥ 779 M¥ 54 M¥ -160 M¥ -365 M¥ 1 B
  Income taxes-current¥ 38 M¥ 39 M¥ 42 M¥ 46 M¥ 41 M¥ 1 B
  Income taxes-deferred¥ -99 M¥ 740 M¥ 12 M¥ -206 M¥ -407 M¥ -573 M
 Income before minority interests¥ 1 B¥ 372 M¥ 4 B
  Valuation difference on available-for-sale securities¥ -207 M¥ 196 M¥ 2 B
  Deferred gains or losses on hedges¥ -11 M¥ 33 M¥ 21 M
  Other comprehensive income¥ -219 M¥ 509 M¥ 2 B
   Comprehensive income attributable to owners of the parent¥ 924 M¥ 881 M¥ 7 B
   Comprehensive income attributable to minority interests--
  Commission fee¥ 129 M¥ 21 M
  Gain on prior period adjustment¥ 27 M-
  Gain on sales of investment securities¥ 48 M¥ 44 M¥ 14 M-
  Other-
  Loss on disaster¥ 193 M-
  Loss on valuation of investment securities¥ 44 M¥ 86 M¥ 6 M¥ 25 M-
  Loss on abandonment of inventories¥ 145 M¥ 332 M-
  Loss on adjustment for changes of accounting standard for asset retirement obligations¥ 51 M-
  Other¥ 22 M-
   Provision for sales returns¥ 10 M¥ 1 M
  Insurance income¥ 63 M¥ 41 M¥ 11 M
  Loss on sales of notes payable¥ 6 M¥ 5 M¥ 4 M¥ 3 M
  Reversal of allowance for doubtful accounts¥ 54 M
    Salaries¥ 2 B¥ 2 B
    Depreciation¥ 244 M¥ 242 M
    Provision for bonuses¥ 308 M¥ 335 M
    Provision for directors' retirement benefits¥ 16 M¥ 16 M
    Retirement benefit expenses¥ 114 M¥ 196 M
    Research and development expenses¥ 2 B¥ 3 B
    Packing and transportation expenses¥ 2 B¥ 2 B
    Other¥ 4 B¥ 4 B
  Miscellaneous income¥ 86 M¥ 72 M¥ 44 M
  Miscellaneous loss¥ 172 M¥ 133 M¥ 144 M
  Environmental expenses¥ 60 M
  Loss on sales of investment securities
  Loss on valuation of other investments¥ 3 M
Consolidated :Cash flow statement (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
  Subtotal¥ 2 B¥ 1 B¥ 2 B¥ 7 B¥ 1 B¥ 3 B
   Depreciation and amortization¥ 2 B¥ 2 B¥ 2 B¥ 2 B¥ 1 B¥ 1 B
   Impairment loss-¥ 319 M
   Increase (decrease) in allowance for doubtful accounts-¥ -79 M----
   Interest and dividends income¥ -76 M¥ -74 M¥ -58 M¥ -57 M¥ -57 M¥ -51 M
   Interest expenses¥ 295 M¥ 297 M¥ 314 M¥ 306 M¥ 262 M¥ 263 M
   Decrease (increase) in notes and accounts receivable-trade¥ 409 M¥ -780 M¥ 152 M¥ 2 B¥ -401 M¥ -3 B
   Decrease (increase) in inventories¥ 380 M¥ -1 B¥ -1 B¥ 984 M¥ -881 M¥ -901 M
   Increase (decrease) in notes and accounts payable-trade¥ -196 M¥ 806 M¥ 367 M¥ -688 M¥ 97 M¥ 831 M
   Loss (gain) on sales of investment securities¥ -44 M-¥ -14 M-¥ 21 M
   Increase (decrease) in provision for bonuses¥ 86 M¥ -86 M¥ 142 M¥ 2 M¥ 137 M
   Increase (decrease) in provision for retirement benefits¥ 159 M¥ 275 M¥ 173 M¥ 228 M¥ 74 M
   Loss (gain) on sales of noncurrent assets¥ -201 M¥ -3 M-¥ -2 B
   Loss on retirement of noncurrent assets¥ 43 M¥ 127 M¥ 89 M¥ 26 M¥ 50 M
   Loss (gain) on investments in partnership¥ -232 M¥ 22 M¥ 138 M¥ 59 M¥ 108 M¥ -180 M
   Other, net¥ -35 M¥ -140 M¥ 1 B¥ -74 M¥ 445 M
  Interest and dividends income received¥ 76 M¥ 73 M¥ 53 M¥ 62 M¥ 57 M¥ 51 M
  Interest expenses paid¥ -317 M¥ -302 M¥ -304 M¥ -302 M¥ -247 M¥ -261 M
  Income taxes paid¥ -59 M¥ -59 M¥ -34 M¥ -48 M¥ -44 M¥ -17 M
  Net cash provided by (used in) operating activities¥ 1 B¥ 1 B¥ 2 B¥ 6 B¥ 884 M¥ 3 B
  Purchase of property, plant and equipment¥ -2 B¥ -2 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B
  Proceeds from sales of property, plant and equipment¥ 1 B¥ 9 M-¥ 3 B
  Purchase of investment securities¥ -52 M¥ -20 M¥ -49 M¥ -307 M¥ -105 M¥ -148 M
  Proceeds from sales of investment securities¥ 236 M¥ 69 M¥ 28 M-¥ 49 M
  Proceeds from withdrawal of time deposits¥ 850 M¥ 336 M-¥ 464 M
  Other, net¥ 81 M¥ -25 M¥ -177 M¥ -145 M¥ -88 M¥ -266 M
  Net cash provided by (used in) investing activities¥ -584 M¥ -2 B¥ -1 B¥ -1 B¥ -1 B¥ 2 B
  Proceeds from long-term loans payable¥ 3 B¥ 3 B¥ 3 B¥ 2 B¥ 4 B¥ 3 B
  Repayment of long-term loans payable¥ -4 B¥ -2 B¥ -3 B¥ -3 B¥ -3 B¥ -3 B
  Redemption of bonds¥ -200 M¥ -750 M¥ -100 M¥ -100 M¥ -100 M¥ -100 M
  Purchase of treasury stock¥ -20 M¥ -24 M¥ -7 M¥ -8 M¥ -3 M¥ -5 M
  Cash dividends paid¥ -543 M¥ -542 M¥ -541 M¥ -542 M¥ -542 M¥ -542 M
  Net increase (decrease) in short-term loans payable¥ 1 B¥ -30 M¥ -3 B¥ 295 M¥ -100 M
  Repayments of lease obligations-¥ -1 M¥ -1 M¥ -1 M¥ -2 M
  Proceeds from sales of treasury stock¥ 2 M¥ 4 M--
  Net cash provided by (used in) financing activities¥ -1 B¥ 55 M¥ -878 M¥ -4 B¥ 943 M¥ -832 M
 Effect of exchange rate change on cash and cash equivalents¥ -6 M¥ -6 M¥ -13 M¥ -1 M-
 Net increase (decrease) in cash and cash equivalents¥ -306 M¥ -1 B¥ -125 M¥ 795 M¥ 445 M¥ 4 B
 Cash and cash equivalents¥ 4 B¥ 3 B¥ 3 B¥ 3 B¥ 4 B¥ 9 B
   Loss (gain) on valuation of investment securities¥ 44 M¥ 86 M¥ 6 M¥ 25 M-
   Loss on adjustment for changes of accounting standard for asset retirement obligations¥ 51 M-
  Proceeds from redemption of investment securities¥ 11 M-
  Payments into time deposits¥ -550 M¥ -996 M¥ -286 M-
  Proceeds from share of profits on investments in capital¥ 293 M¥ 155 M¥ 118 M¥ 26 M¥ 18 M
   Decrease (increase) in other assets¥ 239 M
   Increase (decrease) in other liabilities¥ -149 M
  Income taxes refund¥ 28 M
  Increase in short-term loans payable¥ 4 B
  Decrease in short-term loans payable¥ -4 B
Consolidated :Shareowners' equity (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
    Total changes of items during the period--
     Disposal of treasury stock-¥ -1 M----
     Total changes of items during the period-¥ -1 M----
     Dividends from surplus¥ -544 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M
     Reversal of revaluation reserve for land¥ 326 M¥ 73 M¥ 1 M-¥ 311 M
     Total changes of items during the period¥ -110 M¥ -1 B¥ 48 M¥ 602 M¥ -171 M¥ 4 B
    Purchase of treasury stock¥ -20 M¥ -24 M¥ -7 M¥ -8 M¥ -3 M¥ -5 M
    Disposal of treasury stock¥ 3 M¥ 5 M--
    Total changes of items during the period¥ -16 M¥ -18 M¥ -6 M¥ -7 M¥ -2 M¥ -5 M
    Dividends from surplus¥ -544 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M
    Net income¥ 107 M¥ -931 M¥ 518 M¥ 1 B¥ 372 M¥ 4 B
    Purchase of treasury stock¥ -20 M¥ -24 M¥ -7 M¥ -8 M¥ -3 M¥ -5 M
    Disposal of treasury stock¥ 2 M¥ 4 M--
    Reversal of revaluation reserve for land¥ 326 M¥ 73 M¥ 1 M-¥ 311 M
    Total changes of items during the period¥ -127 M¥ -1 B¥ 42 M¥ 594 M¥ -174 M¥ 4 B
    Net changes of items other than shareholders' equity¥ -979 M¥ -740 M¥ 145 M¥ -207 M¥ 196 M¥ 2 B
    Total changes of items during the period¥ -979 M¥ -740 M¥ 145 M¥ -207 M¥ 196 M¥ 2 B
    Net changes of items other than shareholders' equity¥ -47 M¥ 4 M¥ 3 M¥ -11 M¥ 33 M¥ 21 M
    Total changes of items during the period¥ -47 M¥ 4 M¥ 3 M¥ -11 M¥ 33 M¥ 21 M
    Net changes of items other than shareholders' equity¥ -326 M¥ -73 M¥ -1 M¥ 279 M¥ -311 M
    Total changes of items during the period¥ -326 M¥ -73 M¥ -1 M¥ 279 M¥ -311 M
    Net changes of items other than shareholders' equity¥ -1 B¥ -735 M¥ 75 M¥ -221 M¥ 509 M¥ 1 B
    Total changes of items during the period¥ -1 B¥ -735 M¥ 75 M¥ -221 M¥ 509 M¥ 1 B
   Dividends from surplus¥ -544 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M
   Net income¥ 107 M¥ -931 M¥ 518 M¥ 1 B¥ 372 M¥ 4 B
   Purchase of treasury stock¥ -20 M¥ -24 M¥ -7 M¥ -8 M¥ -3 M¥ -5 M
   Disposal of treasury stock¥ 2 M¥ 4 M--
   Net changes of items other than shareholders' equity¥ -1 B¥ -735 M¥ 75 M¥ -221 M¥ 509 M¥ 1 B
   Reversal of revaluation reserve for land¥ 326 M¥ 73 M¥ 1 M-¥ 311 M
   Total changes of items during the period¥ -1 B¥ -2 B¥ 117 M¥ 373 M¥ 335 M¥ 6 B

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Fuso Pharmaceutical Industries (Annual )

Statement Type
Annual : Fuso Pharmaceutical Industries
First quarter : Fuso Pharmaceutical Industries
Second quarter : Fuso Pharmaceutical Industries
Third quarter : Fuso Pharmaceutical Industries
Analysis Menu
@Outline : Fuso Pharmaceutical Industries
@Statement : Fuso Pharmaceutical Industries
@Rating : Fuso Pharmaceutical Industries
@Indicator : Fuso Pharmaceutical Industries
@Download : Fuso Pharmaceutical Industries
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Osaka - EDIUNET Prefectures
Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ Fuso Pharmaceutical Industries 4538 TSE 1st Chemicals 3 Annual BBB

Related Company

@ 長谷川香料 (Sales ¥ 45 B) +
@ アステラス製薬 (Sales ¥ 1.0 T) +
@ The Nippon Synthetic Chemical Industry (Sales ¥ 91 B) +
@ NIPPON KAYAKU (Sales ¥ 128 B) +
@ NIPPON PAINT (Sales ¥ 233 B) +
@ Hitachi Chemical (Sales ¥ 464 B) +
@ TSUMURA & CO. (Sales ¥ 105 B) +
@ キッセイ薬品工業 (Sales ¥ 62 B) +
@ Dainippon Sumitomo Pharma (Sales ¥ 347 B) +
@ Nichi-Iko Pharmaceutical (Sales ¥ 93 B) +
@ ADEKA (Sales ¥ 184 B) +
@ Mitsubishi Tanabe Pharma (Sales ¥ 419 B) +
@ ROHTO PHARMACEUTICAL (Sales ¥ 129 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.155 sec.)